CANNABIS USE FOR GLAUCOMA AND ASSOCIATED PAIN

Course overview

CANNABIS PLANTS AND THEIR DERIVATIVES DELTA(9)-TETRAHYDROCANNABINOL (THC) AND CANNABIDIOL (CBD) HAVE BEEN EVALUATED FOR THE TREATMENT OF MANY DISORDERS, INCLUDING LOWERING INTRAOCULAR PRESSURE (IOP). CONTROL OF IOP IS THE MOST SIGNIFICANT MODIFIABLE RISK FACTOR FOR GLAUCOMA, AN OPTIC NEUROPATHY THAT CAUSES IRREVERSIBLE BLINDNESS. THIS ACTIVITY REVIEWS CANNABINOIDS’ MECHANISMS OF ACTION IN LOWERING INTRAOCULAR PRESSURE, THEIR POTENTIAL NEUROPROTECTIVE PROPERTIES, AND LOCAL AND SYSTEMIC SIDE EFFECTS.